Home >> Healthcare >> Radioimmunotherapy Market

Global Radioimmunotherapy Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 39 | Pages : 141 | Oct 2024

Report Overview

Radioimmunotherapy (RIT) is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.

The global Radioimmunotherapy market size is projected to grow from US$ 2332 million in 2024 to US$ 5443 million in 2030; it is expected to grow at a CAGR of 15.2% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Radioimmunotherapy Industry Forecast” looks at past sales and reviews total world Radioimmunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Radioimmunotherapy sales for 2023 through 2029. With Radioimmunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioimmunotherapy industry.

This Insight Report provides a comprehensive analysis of the global Radioimmunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioimmunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioimmunotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioimmunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioimmunotherapy.

Global key Companies of Radioimmunotherapy include Novartis, Bayer, etc. The top two players hold a share over 98%. North America is the largest market, with a share about 62%, followed by Europe and Asia-Pacific, with the share about 29% and 8%. In terms of product type, Beta-emitting occupy the largest share of the total market, about 90%. 
This report presents a comprehensive overview, market shares, and growth opportunities of Radioimmunotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Beta-emitting
    Targeted Alpha Therapy

Segmentation by Application:
    Solid Tumor
    Non Hodgkin Lymphoma

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Beta-emitting
    Targeted Alpha Therapy

Segmentation by Application:
    Solid Tumor
    Non Hodgkin Lymphoma

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Bayer
    Novartis
    Lantheus
    Aurobindo Pharma
    Mundipharma
    China Isotope & Radiation
    Curium Pharmaceuticals
    Gilead Sciences
    Clarity Pharmaceuticals
    Curasight
    Nordic Nanovector
    Philogen
    RadioMedix
    Telix Pharmaceuticals
    Orano Med
    Actinium Pharmaceuticals
    Y-mAbs Therapeutics
    Fusion Pharmaceuticals

Frequently Asked Questions?

Ans - The purpose of a Radioimmunotherapy market research report is to provide data-driven insights and analysis on a Radioimmunotherapy market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Radioimmunotherapy market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.